Opportunistic infections (OIs) are the hallmark of the immunodeficiency ass
ociated with HIV infections. In the mid-1990s, widespread use of prophylaxi
s strategies improved the morbidity and mortality of AIDS, and the guidelin
es for the prevention of most infections have been promulgated. More recent
ly, with the introduction of potent antiretroviral therapy, there has been
a dramatic change in clinical outcome of many OIs such that antiretroviral
therapy should be regarded as standard treatment for any OI. In addition, t
he immune reconstitution that follows successful inhibition of HIV replicat
ion raises the question of withdrawal of specific antimicrobial prophylaxis
. In fact, diseases that previously required lifelong maintenance therapy m
ay be potentially curable with effective antiretroviral therapy. In this ar
ticle, the authors update clinicians on the current state of the art of pro
phylaxis of OIs in the era of potent treatment for HIV.